Walking program for children with fatty liver and phenylketonuria

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on children diagnosed with phenylketonuria (PKU) who also suffer from non-alcoholic fatty liver disease. It involves a randomized assignment of 40 participants into two groups: one group will engage in a daily online supervised walking program for eight weeks, while the other group will serve as a waitlist control. The aim is to assess the impact of physical activity on the metabolic complications associated with PKU and fatty liver. The study seeks to provide insights into non-pharmacological interventions for managing these conditions in children.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* PKU children
* obese children
* fatty liver children (non-alcoholic fatty liver)

Exclusion Criteria:

* cardiac children
* diabetic children
* neurogenic disorders
* respiratory and renal problems

Where it's running

• Cairo University
  Dokki, Giza Governorate, Egypt Recruiting

Study contacts

• Study coordinator: Ali Isamil, Lecturer
• Email: ali.mohamed@pt.cu.edu.eg
• Phone: 0201005154209

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease

  This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.

  Recruiting Cairo University · Giza, Dokki · NCT07832994

• Blood markers to detect liver scarring in fatty liver disease

  This will test whether blood markers can detect liver scarring in adults with NAFLD or NASH who are having or recently had a liver biopsy.

  Recruiting at 2 sites Roche Diagnostics GmbH · Copenhagen and 1 other locations · NCT06819917

• Evaluating NGGT002 for treating adult Phenylketonuria

  This study is testing a new gene therapy called NGGT002 to see if it can safely help adults with classic Phenylketonuria lower their blood phenylalanine levels.

  Recruiting at 2 sites Phase 1/2 NGGT (Suzhou) Biotechnology Co., Ltd. · Bengbu, Anhui and 1 other locations · NCT06687733

• New psychological tools and anxiety intervention for adolescents with PKU

  This study is testing a new online program to help teenagers with PKU manage anxiety and depression better over 10 weeks.

  Recruiting University of Missouri-Columbia · Columbia, Missouri · NCT06560736

• Evaluating Large Neutral Amino Acids for Treating Phenylketonuria

  This study is testing if Large Neutral Amino Acids can be a better treatment for adults with Phenylketonuria than the usual diet that limits phenylalanine.

  Recruiting Copenhagen University Hospital, Rigshospitalet · Copenhagen and 1 other locations · NCT06337864

• Gene therapy for adults with classic Phenylketonuria

  This study is testing a new gene therapy called NGGT002 to see if it can help adults with classic Phenylketonuria feel better and manage their condition.

  Recruiting at 5 sites Phase 1/2 Nggt INC. · Orange, California and 4 other locations · NCT06332807

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.